Dova Pharmaceuticals Inc. (DOVA)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
12-Nov-19 4:38 PM
View: 
Manning Paul B
Director
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition (change in control) 1,783,230$27.50$49,038,700.00(100%)
1.78M to 0
12-Nov-19 4:34 PM
View: 
Hahn Mark W
Chief Financial Officer
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 9,024----(100%)
9.02K to 0
12-Nov-19 4:33 PM
View: 
Goldman Steven M.
Director
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 144,280----(97%)
149.28K to 5.0K
12-Nov-19 4:41 PM
View: 
Wysenski Nancy
Director
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 6,274----(100%)
6.27K to 0
12-Nov-19 4:40 PM
View: 
Stalfort Sean
Director
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition (change in control) 635,665$27.50$17,480,800.00(100%)
635.66K to 0
12-Nov-19 4:42 PM
View: 
Zaccardelli David
President & CEO
Director
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 76,647----(100%)
76.65K to 0
15-Nov-19 8:02 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition (other) 3,125,850----(100%)
3.13M to 0
12-Nov-19 4:32 PM
View: 
Allen Lee F Md Phd
Chief Medical Officer
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 9,635----(100%)
9.63K to 0
12-Nov-19 4:33 PM
View: 
Goldman Steven M.
Director
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 5,000----(100%)
5.0K to 0
12-Nov-19 4:38 PM
View: 
Manning Paul B
Director
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition (change in control) 12,979,000$27.50$356,923,008.00(88%)
14.76M to 1.78M
12-Nov-19 4:39 PM
View: 
Novak Alfred J
Director
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 6,901----(100%)
6.9K to 0
12-Nov-19 4:35 PM
View: 
Hoitt Jason
Chief Commercial Officer
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 9,970----(100%)
9.97K to 0
12-Nov-19 4:36 PM
View: 
Jeffs Roger
Director
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 66,993----(100%)
66.99K to 0
12-Nov-19 4:37 PM
View: 
Laliberte Kevin
Sr. VP, Product Development
Dova Pharmaceuticals Inc. (DOVA) 12-Nov-19Disposition 4,761----(100%)
4.76K to 0
02-Oct-19 4:21 PM
View: 
Zaccardelli David
President & CEO
Director
Dova Pharmaceuticals Inc. (DOVA) 01-Oct-19Private Sale (Planned) 5,275$27.90$147,172.00(6%)
81.92K to 76.65K
02-Oct-19 4:20 PM
View: 
Hoitt Jason
Chief Commercial Officer
Dova Pharmaceuticals Inc. (DOVA) 30-Sep-19Private Sale (Planned) 2,387$28.00$66,836.00(19%)
12.36K to 9.97K
02-Oct-19 4:20 PM
View: 
Hahn Mark W
Chief Financial Officer
Dova Pharmaceuticals Inc. (DOVA) 30-Sep-19Private Sale (Planned) 775$28.00$21,700.00(8%)
9.8K to 9.02K
02-Oct-19 4:20 PM
View: 
Laliberte Kevin
Sr. VP, Product Development
Dova Pharmaceuticals Inc. (DOVA) 30-Sep-19Private Sale (Planned) 3,696$28.00$103,488.00(44%)
8.46K to 4.76K
02-Oct-19 4:21 PM
View: 
Allen Lee F Md Phd
Chief Medical Officer
Dova Pharmaceuticals Inc. (DOVA) 30-Sep-19Private Sale (Planned) 978$28.00$27,384.00(9%)
10.61K to 9.63K
27-Sep-19 4:05 PM
View: 
Laliberte Kevin
Sr. VP, Product Development
Dova Pharmaceuticals Inc. (DOVA) 25-Sep-19Private Sale (Planned) 3,100$20.00$62,000.00(27%)
11.56K to 8.46K
12-Aug-19 4:15 PM
View: 
Manning Paul B
Director
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 09-Aug-19Purchase 28,062$15.87$445,344.00< 1%
14.73M to 14.76M
01-Aug-19 4:31 PM
View: 
Laliberte Kevin
Sr. VP, Product Development
Dova Pharmaceuticals Inc. (DOVA) 31-Jul-19Private Sale (Planned) 1,389$15.97$22,182.30(11%)
12.95K to 11.56K
16-Jul-19 4:29 PM
View: 
Hoitt Jason
Chief Commercial Officer
Dova Pharmaceuticals Inc. (DOVA) 15-Jul-19Private Sale (Planned) 7,580$15.26$115,664.00(38%)
19.94K to 12.36K
11-Jul-19 8:31 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 11-Jul-19Purchase 42,916$16.67$715,410.001%
3.67M to 3.71M
11-Jul-19 8:31 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 10-Jul-19Purchase 12,354$16.89$208,659.00< 1%
3.65M to 3.67M
11-Jul-19 8:31 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 09-Jul-19Purchase 29,834$16.61$495,543.00< 1%
3.62M to 3.65M
09-Jul-19 7:43 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 05-Jul-19Purchase 50,000$16.46$823,000.001%
3.58M to 3.63M
03-Jul-19 8:28 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 03-Jul-19Purchase 1,705$16.67$28,422.30< 1%
3.57M to 3.57M
03-Jul-19 4:24 PM
View: 
Zaccardelli David
President & CEO
Director
Dova Pharmaceuticals Inc. (DOVA) 02-Jul-19Private Sale (Planned) 10,450$15.94$166,608.00(11%)
92.37K to 81.92K
03-Jul-19 8:28 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 02-Jul-19Purchase 715$16.14$11,540.10< 1%
3.57M to 3.57M
02-Jul-19 4:58 PM
View: 
Jeffs Roger
Director
Dova Pharmaceuticals Inc. (DOVA) 01-Jul-19Private Sale (Planned) 1,308$14.17$18,534.40(2%)
68.3K to 66.99K
02-Jul-19 4:56 PM
View: 
Allen Lee F Md Phd
Chief Medical Officer
Dova Pharmaceuticals Inc. (DOVA) 01-Jul-19Private Sale (Planned) 1,957$14.19$27,769.80(16%)
12.57K to 10.61K
02-Jul-19 4:57 PM
View: 
Laliberte Kevin
Sr. VP, Product Development
Dova Pharmaceuticals Inc. (DOVA) 01-Jul-19Private Sale (Planned) 1,191$14.17$16,876.50(8%)
14.14K to 12.95K
03-Jul-19 8:28 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 01-Jul-19Purchase 18,121$14.24$258,043.00< 1%
3.55M to 3.57M
02-Jul-19 4:59 PM
View: 
Hahn Mark W
Chief Financial Officer
Dova Pharmaceuticals Inc. (DOVA) 01-Jul-19Private Sale (Planned) 1,545$14.17$21,892.70(14%)
11.34K to 9.8K
01-Jul-19 7:23 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 28-Jun-19Purchase 100,000$14.17$1,417,090.003%
3.45M to 3.55M
02-Jul-19 4:55 PM
View: 
Hoitt Jason
Chief Commercial Officer
Dova Pharmaceuticals Inc. (DOVA) 28-Jun-19Private Sale (Planned) 2,387$13.81$32,963.50(11%)
22.32K to 19.94K
01-Jul-19 7:23 PM
View: 
Perceptive Advisors LLC
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 27-Jun-19Purchase 327,209$13.10$4,286,120.0010%
3.13M to 3.45M
27-Jun-19 4:21 PM
View: 
Goldman Steven M.
Director
Dova Pharmaceuticals Inc. (DOVA) 26-Jun-19Option Exercise 1,750$8.29$14,511.401%
147.53K to 149.28K
13%
24-Jun-19 4:54 PM
View: 
Goldman Steven M.
Director
Dova Pharmaceuticals Inc. (DOVA) 20-Jun-19Option Exercise 1,750$8.29$14,509.301%
145.78K to 147.53K
13%
03-Jun-19 8:35 PM
View: 
Goldman Steven M.
Director
Dova Pharmaceuticals Inc. (DOVA) 13-May-19Option Exercise 3,668$7.32$26,849.803%
142.11K to 145.78K
10-Apr-19 4:48 PM
View: 
Hoitt Jason
Chief Commercial Officer
Dova Pharmaceuticals Inc. (DOVA) 08-Apr-19Market Sale (Planned) 2,387$8.77$20,934.00(10%)
24.71K to 22.32K
3%
08-Mar-19 8:46 AM
View: 
Manning Paul B
Director
10% Owner
Dova Pharmaceuticals Inc. (DOVA) 07-Mar-19Market Purchase 68,000$7.48$508,640.00< 1%
14.67M to 14.73M
(< 1%)
07-Feb-19 4:55 PM
View: 
Wysenski Nancy
Director
Dova Pharmaceuticals Inc. (DOVA) 05-Feb-19Grant 6,274----100%
0 to 6.27K
07-Feb-19 4:57 PM
View: 
Novak Alfred J
Director
Dova Pharmaceuticals Inc. (DOVA) 05-Feb-19Grant 6,901----100%
0 to 6.9K
07-Feb-19 4:59 PM
View: 
Jeffs Roger
Director
Dova Pharmaceuticals Inc. (DOVA) 05-Feb-19Grant 6,901----11%
61.4K to 68.3K
07-Feb-19 5:00 PM
View: 
Goldman Steven M.
Director
Dova Pharmaceuticals Inc. (DOVA) 05-Feb-19Grant 7,528----6%
130.0K to 137.53K
08-Jan-19 4:57 PM
View: 
Allen Lee F Md Phd
Chief Medical Officer
Dova Pharmaceuticals Inc. (DOVA) 04-Jan-19Grant 9,070----259%
3.5K to 12.57K
08-Jan-19 5:01 PM
View: 
Laliberte Kevin
Sr. VP, Product Development
Dova Pharmaceuticals Inc. (DOVA) 04-Jan-19Grant 7,937----128%
6.2K to 14.14K
08-Jan-19 4:59 PM
View: 
Hahn Mark W
Chief Financial Officer
Dova Pharmaceuticals Inc. (DOVA) 04-Jan-19Grant 8,844----354%
2.5K to 11.34K